Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFK7M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,509
Award facts
- Contract value 100% obligated
- $10,509.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,509.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Beyfortus 50 mg/0.5 ml syringes. This contract represents a child award under AmerisourceBergen's parent company, Cencora, Inc., and carries an ultimate completion date of January 15, 2026. The performance location is designated as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal medical procurement requirements through open competition.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Beyfortus is a respiratory syncytial virus (RSV) monoclonal antibody used for immunoprophylaxis, particularly in pediatric populations. The supply of this specialized pharmaceutical product through the DLA Medical Supply Chain supports the Defense Health Agency's mission to provide critical medical commodities to military treatment facilities and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FFK7M?
SPE2DR26FFK7M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FFK7M worth?
The government has obligated $10,509 on SPE2DR26FFK7M.
Is contract SPE2DR26FFK7M an order under another contract?
Yes. SPE2DR26FFK7M is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK7M competed?
The extent of competition for SPE2DR26FFK7M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award